Stockreport

ACADIA Pharmaceuticals Targets $1.7B Sales by 2028, Teases Key Phase 2 Data in 2025 [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF ACADIA Pharmaceuticals (NASDAQ:ACAD) executives outlined the company's revenue outlook, commercial priorities for its two marketed products, and upcoming clinical catal [Read more]